Compare Halliburton Company (HAL) vs McKesson Corporation (MCK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Halliburton Company vs McKesson Corporation — how do they compare? Halliburton Company trades at $33.59 (market cap $28.16B), while McKesson Corporation trades at $891.41 (market cap $105.14B). The key difference: McKesson Corporation is far larger — about 3.7× Halliburton Company's market cap, and Halliburton Company pays the higher dividend (2.01%). Which is the better fit depends on your goals.
| HAL | MCK | |
|---|---|---|
Market Cap | $28.16B | $105.14B |
Sector | Energy | Health |
52-Week High | $42.98 | $995.69 |
52-Week Low | $20.97 | $659.01 |
Enterprise Value | $34.31B | $111.67B |
Dividend Yield | 2.01% | 0.42% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Halliburton (HAL) trades at $33.6, down slightly (-0.12%) on the day. The stock shows a bullish technical signal overall, with recent earnings beats in Q1 and Q2 2026. Revenue for 2025 was $22.18B with a net income margin of 7.16%, though this declined from 2024. The company maintains solid profitability with a 14.89% ROE and recently announced partnerships, including an AI data center-linked gas project in Australia (Reuters, 2026-07-29).
The outlook is supported by a strong analyst consensus (73% Buy ratings) and a $43.60 price target, implying significant upside. Key risks include geopolitical tensions impacting Middle East operations and a potentially softening oilfield services market. Earnings growth from international contract wins remains a primary catalyst for shareholder value.
McKesson (MCK) trades at $879.87, up 1.18% today, with strong momentum from recent earnings beats and raised guidance. The stock shows bullish technical signals, supported by robust revenue growth and solid cash flow generation. Recent news highlights strength in specialty drugs and oncology, driving positive sentiment.
Outlook remains favorable with a consensus price target of $990.67, though thin profit margins and high liabilities pose risks. Continued execution on growth initiatives and cost discipline are key for sustained upside, while macroeconomic pressures and competitive dynamics require monitoring.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Halliburton Company
Halliburton is one of the three largest oilfield service firms in the world, offering superior expertise in a number of business lines, including completion fluids, wireline services, cementing, and countless others. It's the number one pressure pumper in North America, and has been a leading innovator in hydraulic fracturing over the last two decades.
Read more on HAL →About McKesson Corporation
McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →
